Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Stakeholder assessment of the evidence for cancer genomic tests: insights from three case studies.

Genetics in medicine : official journal of the American College of Medical Genetics - 1 Jul 2012

Deverka Patricia A, Schully Sheri D, Ishibe Naoko, Carlson Josh J, Freedman Andrew, Goddard Katrina A B, Khoury Muin J, Ramsey Scott D

Abstract excerpt

PURPOSE: Insufficient evidence on the net benefits and harms of genomic tests in real-world settings is a translational barrier for genomic medicine. Understanding stakeholders' assessment of the current evidence base for clinical practice and coverage decisions should be a critical step in influ...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to Colorectal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colorectal Neoplasms, Hereditary Nonpolyposis

Share to Decision Making

Share to ErbB Receptors

Share to Genomics

Share to Practice Guidelines as Topic

Share to Reproducibility of Results

Source

Open in PubMed Open full text

Identifiers

PMID: 22481130
DOI: 10.1038/gim.2012.3
PMCID: PMC4437504

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22481130-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Stakeholder assessment of the evidence for cancer genomic tests: insights from three case studies.PMID 22481130Read ↗

Preferences for genetic testing to identify hereditary colorectal cancer: perspectives of high-risk patients, community members, and clinicians.Semantic proximity Read ↗

Ethical, legal, and social issues related to genetics and genomics in cancer: A scoping review and narrative synthesisSemantic proximity Read ↗

Public attitudes towards genomic risk profiling as a component of routine population screening.Semantic proximity Read ↗

Understanding patient and provider perceptions and expectations of genomic medicine.Semantic proximity Read ↗

"Is it really worth it to get tested?": primary care patients' impressions of predictive SNP testing for colon cancer.Semantic proximity Read ↗

Uptake of Genetic Testing Among Patients with Cancer At Risk for Lynch Syndrome in the National Health Interview Survey.Semantic proximity Read ↗

Toward the diagnosis of rare childhood genetic diseases: what do parents value most?Semantic proximity Read ↗

Attitudes of patients with cancer about personalized medicine and somatic genetic testing.Semantic proximity Read ↗

Acceptability of, and Information Needs Regarding, Next-Generation Sequencing in People Tested for Hereditary Cancer: A Qualitative Study.Semantic proximity Read ↗

Genetic testing in cancer: a systematic review of patient reported measuresSemantic proximity Read ↗

Decision impact studies, evidence of clinical utility for genomic assays in cancer: A scoping reviewSemantic proximity Read ↗

Evaluation of laboratory perspectives on hereditary cancer panels.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.